市場調查報告書
商品編碼
1252574
全球乳腺X光照相繫統市場按產品(模擬,全場數位(FFDM),乳房斷層合成),技術(屏幕膠片,2D,3D),最終用途(醫院,診所)和全球預測2023-2032Mammography Systems Market - By Product (Analog Systems, Full Field Digital Mammography Systems (FFDM), Breast Tomosynthesis), By Technology (Screen Film, 2D Mammography, 3D Mammography), By End-use (Hospitals, Clinics) & Global Forecast, 2023-2032 |
由於對女性健康的關注日益增加,預計從 2023 年到 2032 年,乳腺X光攝影系統市場將以顯著的複合年增長率增長。
乳房X光照相術是檢測乳腺癌的主要診斷測試之一。 根據美國癌症協會的數據,女性死於乳腺癌的機率為 2.5%。 各個中央政府提供資金來改進篩選程序。 50 至 74 歲的女性有資格獲得免費乳房 X 光檢查。
乳房成像的最新發展是計算機輔助檢測 (CAD) 技術。 在放射科醫生對患者的乳房X光照片進行初步評估後,CAD 技術將圖像作為第二隻眼進行檢查。
乳房X光照相繫統行業按產品,技術,最終用途和地理區域劃分。
根據產品,到 2032 年,模擬系統的價值預計將超過 1.5 億美元。 更好的臨床方法和更高的採用率將推動對模擬系統的需求。 這些系統還提供更先進的篩查,以幫助檢測女性年輕或緻密的乳腺組織。
在技術方面,屏幕膠片乳腺X光攝影系統將在預計期間實現良好增長。 幾十年來,屏幕膠片乳房 X 光攝影系統一直是乳腺癌篩查的標準。 屏幕膠片也是醫學影像中要求最高的測試之一,要求對比度高,細節精細,圖像噪聲低,患者移動少和良好的觀看條件。
就最終用途而言,從 2023 年到 2032 年,醫院部分將獲得顯著收益,因為醫院的乳腺成像設施可為所有年齡段的女性提供全方位的乳腺護理服務。 此外,多學科高科技技術的使用和以患者為中心的治療方法是影響該細分市場增長的主要因素。 此外,醫院熟練專業人員的可用性和改善的臨床結果將推動未來幾年的產品需求。
預計到 2032 年,亞太地區乳腺X光攝影系統市場價值將超過 15 億美元。 年輕人和成年女性癌症發病率的上升以及對早期癌症診斷的需求不斷增長,推動了該地區對篩查測試的需求。 此外,不斷增加的醫療保健支出,越來越多地採用新技術,移動篩查工具的可用性等預計將在未來進一步刺激市場增長。
Mammography Systems Market will likely grow at a significant CAGR over 2023 to 2032 owing to the rising focus on women's health. Mammography is one of the leading diagnostic tests used to detect breast cancer. As per the American Cancer Society, the probability of a woman succumbing to breast cancer is nearly 2.5%. Various central governments are providing funds for improving screening programs. Besides, free mammogram screening services are available for women between 50 and 74 years of ages.
A recent development in breast imaging is computer-aided detection (CAD) technology. After the radiologist has produced an initial assessment of a patient's mammography film, the CAD technology acts as a second set of eyes by examining the image.
Overall, the mammography systems industry is segmented in terms of product, technology, end-use, and region.
Based on the product, the analog system is anticipated to be valued at over USD 150 million by 2032. Better clinical approach outcomes and a higher adoption rate will fuel the demand for analog systems. Besides, these systems deliver enhanced screening that helps detect young and dense breast tissue in women.
Considering the technology, the screen film mammography systems will observe lucrative growth during the estimated timespan. Screen-film mammography systems have been a standard for breast cancer screening for several decades. Besides, screen film is one of the most demanding examinations in medical imaging requiring high contrast, fine detail, low noise images, low patient motion, and appropriate viewing conditions.
By end-use, the hospitals segment will garner substantial gains during 2023-2032 as breast imaging facilities at hospitals offer enhanced breast care services to women of all ages. Besides, the use of multidisciplinary high-technology and patient-centered approaches to care are key factors impacting the segment growth. In addition, the availability of skilled professionals in hospitals and improved clinical outcomes will drive the product demand in the forthcoming years.
Geographically, the Asia Pacific mammography systems market is expected to be valued at over USD 1.5 billion by 2032. The rising incidences of cancer cases and increasing need for early cancer diagnosis among young and adult women will drive the screening procedure demand in the region. In addition, the constantly rising healthcare expenditure, increasing adoption of novel technologies, and availability of mobile screening tools will further spur market growth in the future.